The CC had about as much excitement as a late September ballgame between the Baltimore Orioles and the Kansas City Royals. The excitement of the call doesn't matter. All that matters is if pirfenidone gets approved in the EU. if it gets approved it is a forty dollar stock if disapproved it is 4 dollars or less. this is something like the mnta profile pre approval. if they would have been told by the fda that they needed to run clinical trials it would have been a 4 dollar stock